A role for IL-33–activated ILC2s in eosinophilic vasculitis is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL107202,HL140868
A.P. Giannini Foundation
Grant: n/a
NIAMS NIH HHS
Grant: K08 AR075880
NHLBI NIH HHS
Grant: F32 HL140868
NHLBI NIH HHS
Grant: P01 HL107202
NHLBI NIH HHS
Grant: T32 HL007185
National Institutes of Health
Grant: 5T32HL007185-42
Multidisciplinary Training Program in Lung Disease
National Institutes of Health
Grant: 1P01HL107202-01A1
Administrative Core
National Institutes of Health
Grant: 5F32HL140868-02
Role of ILC2s in lung maintenance and repair
FWCI
1.39
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
Additional file 1 of Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma